Research Site — Newark, Delaware

Public research footprint of Research Site, compiled from the ClinicalTrials.gov public registry.

243

Registered studies

Active

Recruiting now

144

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · HIV · HER2 Positive Breast Cancer

Recently updated registry entries

NCT06868277 — A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line… (Recruiting)
NCT03765918 — Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given… (Active Not Recruiting)
NCT06852222 — A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Research Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.